JENNIFER PARROTT: Open Payments
NPI 1275812133 · FRANKLIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,048 in 107 payments from 23 companies in 2025. Trend: 2023 $129 · 2024 $2,331 · 2025 $2,048
Food & beverage: $1,935Education: $113
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 23 | $303 |
| Janssen Biotech, Inc. | 10 | $254 |
| GENZYME CORPORATION | 10 | $251 |
| Novartis Pharmaceuticals Corporation | 9 | $203 |
| UCB, Inc. | 11 | $201 |
| ABBVIE INC. | 12 | $195 |
| Regeneron Healthcare Solutions, Inc. | 4 | $115 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| SOBI, INC | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 3 | $54 |
Products named: DUPIXENT, TREMFYA, Bimzelx, COSENTYX, RINVOQ, KRYSTEXXA, KEVZARA, ENBREL.
Industry payments across KY — which companies pay providers there.
